Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates

Jun 21, 2022

This episode discusses the evidence and benefits of topiramate and stimulant replacement therapy for cocaine use disorder. It also addresses the use of these medications when there are comorbidities, such as alcohol use disorder and ADHD. 

Faculty: Andrew Saxon, M.D. 
Hosts: Jessica Diaz, M.D.


Jun 16, 2022

In this episode, we discuss the problem of pre-existing mood disorders increasing the risk of hospitalization and death among people infected with COVID-19. Why does this occur?

Faculty: Jim Phelps, M.D.
Host: Jessica Diaz, M.D.


Jun 11, 2022

This episode discusses the evidence of mirtazapine, bupropion, and naltrexone for stimulant use disorder. Are these promising treatments? Are they really effective? 

Faculty: Andrew Saxon, M.D. 
Host: Jessica Diaz, M.D.


Jun 6, 2022

Can we use ketamine as a maintenance treatment for MDD?
In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD.

Faculty: Jim Phelps, M.D.
Host: Jessica Diaz, M.D.


Jun 1, 2022

Can methylphenidate help amphetamine and methamphetamine use disorder? This episode discusses stimulant replacement therapies for methamphetamine and amphetamine use disorder. This includes the possible use of MPH in patients with underlying ADHD. 

Faculty: Andrew Saxon, M.D. 
Host: Jessica Diaz, M.D.